Results 161 to 170 of about 629,767 (276)

Update on HIV prevention and management in pregnancy Number 10 - 2025. [PDF]

Rev Bras Ginecol Obstet
Kreitchmann R, Duarte G, Milanez H, Travassos AG, Traina É, Miranda AE, Menezes MLB.   +6 more
europepmc   +1 more source

Corrigendum to – “Single oral dose for HIV pre or post-exposure prophylaxis: user desirability and biological efficacy in macaques” [eBioMedicine 58(2020) 102894]

EBioMedicine
Ivana Massud, Susan Ruone, Maria Zlotorzynska, Richard Haaland, Patrick Mills, Mian-er Cong, Kristen Kelley, Ryan Johnson, Angela Holder, Chuong Dinh, George Khalil, Yi Pan, Colleen F. Kelley, Travis Sanchez, Walid Heneine, J. Gerardo García-Lerma   +15 more
doaj   +1 more source

Person-centred HIV prevention services in sub-Saharan Africa: a scoping review. [PDF]

AIDS Res Ther
Asogun D, Larbi-Ampofo AK, Akhaine JO, Abiodun MA, Enotiuwa P, Aikhenomian P, Idialu PO, Ekhabafe MB, Okhihan IB.   +8 more
europepmc   +1 more source

The female microbiome in HIV prevention, pathogenesis, and treatment. [PDF]

Curr Opin HIV AIDS
Peters BA, Usyk M, Burk RD.
europepmc   +1 more source

Person-centred HIV prevention in an era of innovation and uncertainties. [PDF]

J Int AIDS Soc
Mujugira A, Azwa I, Lavoie MC.
europepmc   +1 more source

HIV prevention strategies

Medicine, 2022
Cabecinha, MA, Saunders, J
openaire   +2 more sources

National and Subnational Models of Care That Support Primary Health Care: A Mixed‐Methods Study

The International Journal of Health Planning and Management, EarlyView.
ABSTRACT In 2020, the World Health Assembly called on countries to reorient their models of care (MOCs) toward primary health care (PHC). This study's objectives were to (a) describe common use of the concept of MOC; and (b) identify implemented MOCs and their components that support PHC at national and subnational levels. A scoping review charted data
Mary Louisa Plummer, Nuria Toro Polanco, Faraz Khalid, Fidan Talishinskaya, Hassan Salah, Teri Reynolds   +5 more
wiley   +1 more source

PrEP public policies for HIV prevention in South America: an intersectional analysis. [PDF]

BMC Public Health
de Oliveira KH, de Oliveira Ferreira B, da Silva Junior FJ, Barp LFG, de Menezes Guerra CB, da Silva Câmara FD, de Almeida Soares MA, Bercht G, Honorato IB, Gagliolo AA, García MG, Dos Reis RP, Passamani GR, Kauss BS, Vallejo FR, Hurtado JCA, das Neves ALM.   +16 more
europepmc   +1 more source

Nonavalent HPV vaccine to prevent recurrent anal or vulvar high‐grade squamous intraepithelial lesions (VIVA trial): A randomized, double‐blind, placebo‐controlled trial

International Journal of Cancer, EarlyView.
What's New? Anal and vulvar high‐grade squamous intraepithelial lesions (HSILs) frequently recur following treatment. Additional genital and anal procedures, however, can be distressing for patients and are potentially disfiguring. This trial assessed whether the 9‐valent human papillomavirus (9vHPV) vaccine reduces HSIL recurrence risk or HPV ...
Helen C. Stankiewicz Karita, Amalia S. Magaret, David R. Doody, Jeffrey T. Schouten, Constance Mao, Warner K. Huh, Verena S. Grieco, Matthew A. Seymour, Dana Varon, Kelly H. Shrader, Long Fu Xi, Denise A. Galloway, Anna Wald, Margaret M. Madeleine   +13 more
wiley   +1 more source

Antiviral regulator TRIM25 as a prognostic marker of better survival in Merkel cell carcinoma: Association with MCPyV status

International Journal of Cancer, EarlyView.
What's New? TRIM25 is known for its role in antiviral immunity and association with poor prognosis in various cancers. This study reveals an association between high TRIM25 expression and Merkel cell polyomavirus positivity in Merkel cell carcinoma.
Klaus W. Fagerstedt, Sami Kilpinen, Johanna Arola, Benjamin Z. Sundqvist, Tom Böhling, Leif C. Andersson, Harri Sihto   +6 more
wiley   +1 more source